March 9, 2017 / 5:04 PM / 7 months ago

BRIEF-Pharnext announces R&D agreement with Galapagos

March 9 (Reuters) - Pharnext SAS:

* Announces R&D agreement with Galapagos to generate a new pipeline of synergistic drug combinations

* Main goal of this agreement is to generate an additional pipeline of novel synergistic drug combinations in a broad set of indications Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below